Rocky joins the Sherpa team, relocating from Boston to San Diego, to lead Sherpa's Quality compliance mission and take Sherpa to the highest level of service excellence.
Rocky comments, "I am dedicated to ensuring that Sherpa has the highest level of quality and compliance and I look forward to continue to bring that quality of service to Sherpa's current and future clients."
Rocky is not new to the clinical supply chain and quality assurance. She brings 20 years of GXP experience leading cross-functional teams in both Quality and Operations. She has extensive experience working for renowned Pharma and Biotech companies such as Audit Proof Inc., Vertex, Takeda, Genzyme, Biogen, Dow, Feinstein Keane Healthcare and Dana Farber. Her career has spanned the entire CMC process of Clinical and Commercial supply chain from materials management, cell banking, DS, DP to Packaging and Labeling.
Rocky has held various management positions in her career, overseeing quality assurance of commercial and clinical product lines including final drug disposition for human use. She has led many international projects in the areas of Compliance and Regulatory Strategy, Vendor and Risk management, Auditing, Remediation, QMS architecture and GXP training. She comes to Sherpa with global quality experience having worked on assignments in Europe and Asia. Ms. Kok received her Bachelor of Science degree in Biology from the Simmons College in Boston.
"I am greatly pleased to announce the addition of Rocky to Sherpa's leadership team," said Mark Paiz, president of Sherpa Clinical Packaging. "She brings a wealth of knowledge and experience and will be instrumental in maintaining the high quality standards of Sherpa."